Skip to content
Main Navigation
About us
Company profile
Our values
Our strategy
Board of Directors
Senior management
Our history
Research and development
Technology platform
Therapeutic areas
Pipeline
Scientific papers and presentations
Partnering
Our approach
Our partnerships
Investors
Financial reports and presentations
Share information
Analyst coverage
Major shareholders
Financial calendar
Corporate governance
Corporate governance statements
Dividend policy
Annual general meeting
Articles of association
Safe harbour statement
Whistleblower policy
Risk management
Investor relations policy
ESG
Email alerts
Newsroom
Press Releases
Image library
Glossary
Email alerts
Careers
Life at Nykode
Meet us
Open positions
Search
Research and development
Scientific papers and presentations
Sharing our discoveries and developments in our tireless pursuit of breakthrough therapies
Newest first
Oldest first
Posters & Papers
Presentations
Search
Reset
22/03/2022
Keystone Symposium: Cancer Immunotherapy | Targeting Cancer Antigens to Antigen Presenting Cells to Elicit Rapid, Broad and Dominant CD8 T Cell Responses
08/03/2022
2022 AACR | Abstract #: 2332 | A novel and versatile cytokine empowered DNA vaccine platform with superior immune activating potential
22/07/2021
Using an Inflammatory Chemokine Linked to the Antigen Generates a Rapid, Strong and Broad Immune Response
26/04/2021
Targeting antigens to antigen presenting cells induce effective anti-tumor efficacy as monotherapy and as combination therapy
26/01/2021
Single dose immunization with a COVID-19 DNA vaccine encoding a chimeric homodimeric protein targeting receptor binding domain (RBD) to antigen-presenting cells induces rapid, strong and long-lasting neutralizing IgG, Th1 dominated CD4+ T cells and strong CD8+ T cell responses in mice
Pages:
1
2
3
4
5
6
7
8
9
Load more
Sorry, nothing found in this query
Privacy statement
Cookie policy
Disclaimer
